27th National Clinical Education Symposium Presentation Abstracts

Actions for Presentation

Download PDF Back to list

Other presentations

Examination of the Relationship between Psychosomatic Diagnosis and Interpersonal Relationships in Patients with Functional Neurological Symptom Disorder - Page 131-132
ANAS HAVARI, Mine Özkan, Nerses Bebek, Ayse Deniz Elmali, Candan Gurses, İrem Erkent, Irmak Polat

Early-onset Psychosis following methylphenidate use in a patient with ADHD diagnosis - Page 133
Merve Sena Kırmacı

Postpartum Psychosis Following Eclampsia: Early Follow-Up of a Case - Page 134
Alperen Kanıvar, Ayse Erguner Aral, Esin Erdogan

Bipolar Disorder Type II Depressive Episode and Anorexia Nervosa Restrictive Type Comorbidity: A Case of Recurrent Suicide Attempts - Page 135
Munise Dinçarslan, Ayse Erguner Aral, Esin Erdoğan

Behavioral Variant of Alzheimer's Disease: An Atypical Case Supported by CSF Biomarkers - Page 136
Koray Hamza Cihan, Kübra Özçelik, Kazım Cihan Can, Erguvan Tuğba Özel Kızıl

A Case Study: Myositis Due To Clozapine Use - Page 137
Mehmet Eren Yaşaran, Soner Akar, Cansu Bak, Aslıhan Özdemir Yaşaran, Figen Ünal Demir

30 APRIL 2025, WEDNESDAY
10.30-11.45 ORAL PRESENTATION SESSION - 13

Transcranial Magnetic Stimulation Treatment Practices in a University Hospital

Hakan Emre BABACAN1, Ömer faruk uygur1, Oğuz Erçelik1, Halil Ozcan1

1. Department of Psychiatry, Ataturk University Faculty of Medicine, Erzurum, Türkiye

DOI: 10.5080/kes27.abs105 Page 130

BACKGROUND AND AIM:Transcranial magnetic stimulation (TMS) is a non-invasive, well-tolerated treatment modality that does not require anesthesia and has no serious side effects.TMU has been indicated in depression and obsessive-compulsive disorder, but its use in schizophrenia, post-traumatic stress disorder and substance use disorder is under investigation.In this study, we aimed to present one-year TMU treatment experiences in a university hospital.
METHODS (Ethics Committee Approval must be obtained and the number should be specified.):The files of patients who received TMU treatment in our TMU unit in the last one year were reviewed.Descriptive analyses of sociodemographic, clinical and TMU protocol information were performed.Our study was approved by Atatürk University Faculty of Medicine Ethics Committee (07.06.2024/100).
RESULTS:175 TMU application files were accessed, but 9 of these files were excluded from the study because they were re-application to the same patient, and a total of 166 patient files were included in the study.The mean age of the patients was 39.50±14.42 years(min-max:18-83),62.7% were female(s=104) and 37.3% were male(s=62).The most common diagnoses of patients who underwent TMU were unipolar depression(s=88,53%),obsessive-compulsive disorder (s=36,21.7%),and bipolar depression(s=15,9%),respectively.In 31.3%(s=52) of patients who underwent TMU,TMU was administered during hospitalization.The most common TMU protocol was intermittent theta burst to the left dorsalateral prefrontal cortex (DLPFC) with continuous theta burst to the right DLPFC (s=48,28.9%) and TMU was most commonly applied to the left and right DLPFC regions(s=81,48.8%).Accelerated TMU treatment of more than one session per day was applied to 42.8% of patients(s=71).During TMU treatment,67.8%(s=61) of the patients who were followed up with clinical scales responded to the treatment.44 patients(26.5%) discontinued TMU treatment and the most common side effect during TMU treatment was headache(s=19,11.4%).
CONCLUSIONS:In our clinic, short-term sessions and TMU treatment to DLPFC were preferred in order to reach more patients. Considering that TMU is applied to resistant patients, it is another important result that the response rate to treatment was quite high in our study.